This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cooper, B.
Right arrow Articles by Vande Pol, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cooper, B.
Right arrow Articles by Vande Pol, S. B.

 Previous Article  |  Next Article 

Journal of Virology, November 2007, p. 12675-12679, Vol. 81, No. 22
0022-538X/07/$08.00+0     doi:10.1128/JVI.01083-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Human Papillomavirus E6 Regulates the Cytoskeleton Dynamics of Keratinocytes through Targeted Degradation of p53{triangledown}

Brooke Cooper, Nicole Brimer, and Scott B. Vande Pol*

Department of Pathology, University of Virginia School of Medicine, Charlottesville, Virginia

Received 19 May 2007/ Accepted 27 August 2007

The attachment and spreading of keratinocyte cells result from interactions between integrins and immobilized extracellular matrix molecules. Human papillomavirus type 16 (HPV-16) E6 augmented the kinetics of cell spreading, while E6 genes from HPV-11 or bovine papillomavirus type 1 did not. The ability of E6 to interact with the E6AP ubiquitin ligase and target p53 degradation was required to augment cell-spreading kinetics; dominant negative p53 alleles also enhanced the kinetics of cell spreading and the level of attachment of cells to hydrophobic surfaces. The targeted degradation of p53 by E6 may contribute to the invasive phenotype exhibited by cervical cells that contain high-risk HPV types.


* Corresponding author. Mailing address: Department of Pathology, University of Virginia, P.O. Box 800904, Charlottesville, VA 22908. Phone: (434) 924-1603. Fax: (434) 924-1545. E-mail: vandepol{at}virginia.edu

{triangledown} Published ahead of print on 5 September 2007.


Journal of Virology, November 2007, p. 12675-12679, Vol. 81, No. 22
0022-538X/07/$08.00+0     doi:10.1128/JVI.01083-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.